Medicon Hellas S.A. (ATH:MEDIC)
2.250
-0.050 (-2.17%)
Feb 21, 2025, 10:30 AM EET
Medicon Hellas Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 17.99 | 18.72 | 20.77 | 21.51 | 15.27 | 13.45 | Upgrade
|
Revenue Growth (YoY) | -8.08% | -9.89% | -3.41% | 40.87% | 13.51% | -2.34% | Upgrade
|
Cost of Revenue | 5.2 | 5.3 | 5.29 | 5.82 | 3.99 | 3.27 | Upgrade
|
Gross Profit | 12.79 | 13.41 | 15.48 | 15.69 | 11.28 | 10.18 | Upgrade
|
Selling, General & Admin | 10.91 | 10.77 | 10.99 | 10.13 | 8.82 | 8.38 | Upgrade
|
Research & Development | 0.9 | 0.92 | 0.77 | 0.91 | 0.84 | 0.68 | Upgrade
|
Other Operating Expenses | -0.19 | -0.24 | -0.12 | -0.34 | 0.05 | 0.02 | Upgrade
|
Operating Expenses | 11.62 | 11.45 | 11.63 | 10.7 | 9.7 | 9.08 | Upgrade
|
Operating Income | 1.17 | 1.96 | 3.85 | 4.99 | 1.58 | 1.1 | Upgrade
|
Interest Expense | -0.62 | -0.58 | -0.26 | -0.27 | -0.3 | -0.32 | Upgrade
|
Interest & Investment Income | 0.65 | 0.58 | 0.15 | 0.13 | 0.23 | 0.79 | Upgrade
|
Currency Exchange Gain (Loss) | -0 | -0 | -0.01 | -0.02 | 0.01 | -0 | Upgrade
|
Other Non Operating Income (Expenses) | -0.31 | -0.31 | -0.07 | -0.08 | -0.07 | -0.05 | Upgrade
|
EBT Excluding Unusual Items | 0.88 | 1.65 | 3.66 | 4.74 | 1.45 | 1.52 | Upgrade
|
Gain (Loss) on Sale of Investments | -0 | -0 | 0 | - | - | -0 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.01 | 0.02 | -0 | 0.03 | -0 | 0.01 | Upgrade
|
Pretax Income | 0.88 | 1.67 | 3.66 | 4.78 | 1.45 | 1.53 | Upgrade
|
Income Tax Expense | -0.04 | 0.23 | 0.96 | 1.54 | 0.63 | 0.68 | Upgrade
|
Earnings From Continuing Operations | 0.92 | 1.44 | 2.7 | 3.24 | 0.82 | 0.85 | Upgrade
|
Minority Interest in Earnings | -0.08 | -0.12 | -0.17 | -0.2 | -0.06 | -0.07 | Upgrade
|
Net Income | 0.82 | 1.32 | 2.53 | 3.04 | 0.76 | 0.78 | Upgrade
|
Net Income to Common | 0.82 | 1.32 | 2.53 | 3.04 | 0.76 | 0.78 | Upgrade
|
Net Income Growth | -60.07% | -47.83% | -16.68% | 301.85% | -2.40% | -57.65% | Upgrade
|
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
EPS (Basic) | 0.19 | 0.30 | 0.57 | 0.69 | 0.17 | 0.18 | Upgrade
|
EPS (Diluted) | 0.19 | 0.30 | 0.57 | 0.69 | 0.17 | 0.18 | Upgrade
|
EPS Growth | -60.07% | -47.83% | -16.68% | 301.85% | -2.40% | -57.65% | Upgrade
|
Free Cash Flow | 0.67 | -0.72 | 0.84 | 4.24 | 2.34 | -0.27 | Upgrade
|
Free Cash Flow Per Share | 0.15 | -0.16 | 0.19 | 0.96 | 0.53 | -0.06 | Upgrade
|
Dividend Per Share | 0.060 | 0.060 | 0.153 | - | - | - | Upgrade
|
Dividend Growth | -60.82% | -60.82% | - | - | - | - | Upgrade
|
Gross Margin | 71.09% | 71.67% | 74.52% | 72.94% | 73.90% | 75.68% | Upgrade
|
Operating Margin | 6.51% | 10.47% | 18.52% | 23.18% | 10.35% | 8.18% | Upgrade
|
Profit Margin | 4.56% | 7.06% | 12.20% | 14.14% | 4.96% | 5.76% | Upgrade
|
Free Cash Flow Margin | 3.73% | -3.83% | 4.05% | 19.70% | 15.33% | -1.99% | Upgrade
|
EBITDA | 2.49 | 3.26 | 5.09 | 6.13 | 2.48 | 1.92 | Upgrade
|
EBITDA Margin | 13.82% | 17.42% | 24.53% | 28.50% | 16.21% | 14.27% | Upgrade
|
D&A For EBITDA | 1.31 | 1.3 | 1.25 | 1.14 | 0.9 | 0.82 | Upgrade
|
EBIT | 1.17 | 1.96 | 3.85 | 4.99 | 1.58 | 1.1 | Upgrade
|
EBIT Margin | 6.51% | 10.47% | 18.52% | 23.18% | 10.35% | 8.18% | Upgrade
|
Effective Tax Rate | - | 13.72% | 26.14% | 32.15% | 43.70% | 44.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.